Association of patient characteristics and insurance type with anti‐obesity medications prescribing and fills
Authors' conclusion
Significant disparities exist in access to AOM both at the prescribing stage and getting the prescription filled based on patient characteristics and insurance type.
Study context
- Population
- Adults with BMI ≥30 kg/m² who attended ≥1 weight-management programme or had an initial anti-obesity medication (AOM) prescription, 1 July 2015–31 December 2022; mean BMI 38 ± 8 kg/m²
- Participants
- 50,678 adults
- Outcome
- AOM prescription (naltrexone-bupropion, orlistat, phentermine-topiramate, liraglutide 3.0 mg, semaglutide 2.4 mg) and AOM fill
- Follow-up
- Study (4.7 ± 2.4 years)
Methodological detailselectronic health records, large health system in Ohio and Florida
- Electronic health records
- Large health system in Ohio and Florida
Main finding
As reported in the abstract
Cohort with AOM prescriptions
8.0%
Cohort with filled prescriptions
4.4%
Observational data: associations, not effects.
Original publication
Association of patient characteristics and insurance type with anti‐obesity medications prescribing and fills. Diabetes Obes Metab. Published 29 January 2024. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →